These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 30501711)

  • 1. [Effects of Abnormal Iron Metabolism on EPO-STAT5 Signaling Pathway in Anemia Patients].
    Zhang Y; Han S; Guo C; Zhang QX; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1726-1730. PubMed ID: 30501711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of iron chelation therapy on EPO-STAT5 signalling pathway and EPO resistance in iron-overloaded low-risk myelodysplastic syndrome patients.
    Zhang Y
    Hematology; 2020 Dec; 25(1):1-10. PubMed ID: 31838956
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relationship between tumor necrosis factor alpha, interleukin-6 and erythropoietin in children's with chronic anemia and influence of recombinant human tumor necrosis factor alpha on erythropoietin gene expression].
    Zhai XW; Wu Y; Gu XF; Lu FJ
    Zhonghua Er Ke Za Zhi; 2004 Jan; 42(1):62-5. PubMed ID: 14990112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iron chelation therapy and its influence on the alleviation of EPO resistance in MDS patients].
    Zhang Y; Xiao C; Gu SC; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1027-32. PubMed ID: 25130822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
    Landau D; London L; Bandach I; Segev Y
    PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical Significance of the Serum EPO Level in Patients with Iron Deficiency Anemia].
    Xue CE; Shen QH; Wang Y; Zhang JY; Lin FR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1410-4. PubMed ID: 26524048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic intermittent hypobaric hypoxia improves iron metabolism disorders via the IL-6/JAK2/STAT3 and Epo/STAT5/ERFE signaling pathways in metabolic syndrome rats.
    Cui F; Sun J; Mi H; Li B; Tang L; Wang R; Du Y; Guo B; Li Y; Shi M
    J Trace Elem Med Biol; 2023 Sep; 79():127259. PubMed ID: 37413927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of serum transferrin receptor in differential diagnosis of anemia].
    Chen JL; Li SL; Xu M; Wang HB; Ge CW; Li RS
    Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):423-5. PubMed ID: 15312435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin induces sustained phosphorylation of STAT5 in primitive but not definitive erythrocytes generated from mouse embryonic stem cells.
    Tsuji-Takayama K; Otani T; Inoue T; Nakamura S; Motoda R; Kibata M; Orita K
    Exp Hematol; 2006 Oct; 34(10):1323-32. PubMed ID: 16982325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on serum erythropoietin levels in patients with hematologic malignancies].
    Han B; Shi YK; Zhu J; He XH; Lin NJ; Li SL; Shen T
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):543-5. PubMed ID: 17172129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum transferrin receptor level in anemia of chronic disorders indicates coexistent iron deficiency.
    Das Gupta A; Abbi A
    Am J Hematol; 2003 Mar; 72(3):158-61. PubMed ID: 12605386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
    Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
    Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-Regulation of Cardiac Erythropoietin Receptor and its Downstream Activated Signal Transducer Phospho-STAT-5 in a Rat Model of Chronic Kidney Disease.
    Hertzberg-Bigelman E; Barashi R; Levy R; Cohen L; Ben-Shoshan J; Keren G; Entin-Meer M
    Isr Med Assoc J; 2016 Jun; 18(6):326-30. PubMed ID: 27468524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction.
    Okonko DO; Marley SB; Anker SD; Poole-Wilson PA; Gordon MY
    Int J Cardiol; 2013 Apr; 164(3):359-64. PubMed ID: 21821297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Soluble transferrin receptor and erythropoietin in chronic disease anemia with or without iron deficiency].
    Díaz de Domingo NB; Lardo MM; Gasparini S; Grinspon D; Cantenys N; Carbia CD; Merelli A; Sánchez Avalos JC
    Medicina (B Aires); 2001; 61(5 Pt 1):552-6. PubMed ID: 11725764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.